Brainlab and Magic Leap Partner in Digital Surgery

BrainlabBrainlab has announced a strategic development partnership with Florida-based Magic Leap, a developer of proprietary spatial computing solutions that help users enrich their real world experience by integrating digital content within their physical world.

Under an exclusive agreement, Brainlab will market a version of Magic Leap's technology platform that will redefine how surgeons and other clinicians visualize and access medical imaging data. A state-of-the-art operating system will combine Brainlab data management, cloud computing, visualization and data pre-processing software with Magic Leap's spatial computing and experiential platforms. Open to third parties interested in developing medical spatial computing applications in the fields of surgery, radiotherapy and other critical medical interventions, the combined solution from Magic Leap and Brainlab will transform the art and science of patient care.

"Truly unique and first-of-its-kind, our operating system will enable anyone to integrate multi-dimensional virtual data into real-world clinical workflows, driving precision, productivity and an intuitive user experience," said Stefan Vilsmeier, Founder and CEO of Brainlab. "We will deploy mixed reality and machine learning to capture vital data that will allow physicians to optimize their procedures for every patient."

This spatial computing development ecosystem will support management, visualization, augmentation and navigation of diagnostic imaging data for a broad range of clinical procedures. The first release will enable planning and simulation of interventional procedures in an office setting, which will be expanded upon quickly to include a next-generation mix of virtual and physical worlds for the operating room, radiotherapy treatment room, intensive care room and radiology suite.

"The combination of Brainlab and Magic Leap can be meaningful in empowering physicians to improve the quality of interventional solutions," said Rony Abovitz, Founder and CEO of Magic Leap. "Together we hope to positively impact the lives of millions of people around the world."

About Brainlab

Brainlab develops, manufactures and markets software-driven medical technology, enabling access to advanced, less invasive patient treatments.

Brainlab technology powers treatments in radiosurgery as well as numerous surgical fields including neurosurgery, orthopedic, ENT, CMF, spine and trauma. Founded in Munich in 1989, Brainlab has over 12,300 systems installed in over 100 countries.

Most Popular Now

Merck and Tencent Announce Collaboration…

Merck, a leading science and technology company, signed a strategic collaboration agreement with Tencent, a leading provider of Internet value added services. The collaboration will primarily focus on increasing public...

Merck Granted U.S. Patent for Novel Comb…

Merck, a leading science and technology company, today announced that it has been granted Patent No. US 10,193,695 by the United States Patent and Trademark Office (USPTO). The patent relates...

Applications Now Open for Pioneering Dig…

The Yorkshire & Humber AHSN (Academic Health Science Network), in partnership with mHabitat, announces that applications for the 2019 Propel@YH digital health accelerator programme are now open. Propel@YH has been...

The European Health Catapult Program for…

Through dedicated sessions, a group of international top-level investors, key healthcare leaders and industry stakeholders work closely together challenging 40+ ambitious startups to optimize their business plan and strengthen their...

Flagship Axe the Fax Trust Rolls out Hyb…

Leeds Teaching Hospitals NHS Trust (LTHT), the organisation at the forefront of the national Axe the Fax campaign, is implementing an electronic fax solution to tackle its last remaining machines...

First EU Citizens Using ePrescriptions i…

The first EU patients can use digital prescriptions issued by their home doctor when visiting a pharmacy in another EU country: Finnish patients are now able to go to a...

Final Report: Provision of a Market Stud…

The aim of the study is to examine the telemedicine market in Europe and to understand the factors that determine its development. The analysis maps telemedicine applications and solutions, and...

Open Access Drug Development Tools Featu…

New open access tools for drug development, obesity, and the environmental impacts of medicines are the focus of a new IMI2 Call for proposals launched today. The total budget of...

Boehringer Ingelheim (Canada) Ltd. and I…

Boehringer Ingelheim (Canada) Ltd. and IBM Canada announced at the Healthcare Information and Management Systems Society (HIMSS) conference in Orlando, Florida, their plans to explore the use of blockchain technology...

The NHS Long Term Plan: Cracking the Da …

Opinion Article by Prof. Michael Thick, Chief Medical Officer, Chief Clinical Information Officer, IMS MAXIMS Reading the NHS Long Term Plan this week, I had a definite sense of déjà vu...

Highland Marketing Advisory Board Respon…

The first meeting of Highland Marketing's newly expanded advisory board discussed the NHS Long Term Plan and what will be needed to make it a success. Structural change, leadership, investment...